Neuropsychological Sequelae and Long COVID-19 Fatigue
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Tobacco Use and the Risk of COVID-19 and Adverse Outcomes
- Status
- COMPLETED
- Phase
- N/A
Non-inferiority Trial on Treatments in Early COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Barriers and Facilitators of Key Stakeholders to Implement Remote Monitoring Technologies: a Mixed-methods Analysis
- Status
- COMPLETED
- Phase
- N/A
Online Training for the Reconstitution of Fosun/BioNTech
- Status
- COMPLETED
- Phase
- NA
The Effect of Home-based Rehabilitation Program After COVID-19 Infection
- Status
- TERMINATED
- Phase
- NA
COVID-19 Echo Study
- Status
- COMPLETED
- Phase
- N/A
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
- Status
- TERMINATED
- Phase
- NA
Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries
- Status
- COMPLETED
- Phase
- N/A
Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE4
SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey
- Status
- UNKNOWN
- Phase
- N/A
Variants of SARS-CoV-2 Causing COVID-19 in Africa
- Status
- UNKNOWN
- Phase
- N/A
Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients
- Status
- COMPLETED
- Phase
- NA
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination Among Israeli Health Care Workers
- Status
- COMPLETED
- Phase
- N/A
Randomized Controlled Clinical Trial to Evaluate The Efficacy and Safety of Healthtone as Prophylaxis for COVID-19
- Status
- COMPLETED
- Phase
- NA